These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 19375360

  • 1. Nephrogenic systemic fibrosis and management of high-risk patients.
    Altun E, Semelka RC, Cakit C.
    Acad Radiol; 2009 Jul; 16(7):897-905. PubMed ID: 19375360
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Current status of gadolinium toxicity in patients with kidney disease.
    Perazella MA.
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):461-9. PubMed ID: 19201920
    [Abstract] [Full Text] [Related]

  • 4. Nephrogenic systemic fibrosis.
    Weinreb JC, Kuo PH.
    Magn Reson Imaging Clin N Am; 2009 Feb; 17(1):159-67. PubMed ID: 19364606
    [Abstract] [Full Text] [Related]

  • 5. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
    Prince MR, Zhang HL, Prowda JC, Grossman ME, Silvers DN.
    Radiographics; 2009 Oct; 29(6):1565-74. PubMed ID: 19959508
    [Abstract] [Full Text] [Related]

  • 6. Contrast-induced nephropathy and nephrogenic systemic fibrosis: minimizing the risk.
    Nicholas BA, Vricella GJ, Smith M, Passalacqua M, Gulani V, Ponsky LE.
    Can J Urol; 2012 Feb; 19(1):6074-80. PubMed ID: 22316507
    [Abstract] [Full Text] [Related]

  • 7. Nephrogenic systemic fibrosis and gadolinium-based contrast agents.
    Abu-Alfa AK.
    Adv Chronic Kidney Dis; 2011 May; 18(3):188-98. PubMed ID: 21531325
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
    Kribben A, Witzke O, Hillen U, Barkhausen J, Daul AE, Erbel R.
    J Am Coll Cardiol; 2009 May 05; 53(18):1621-8. PubMed ID: 19406336
    [Abstract] [Full Text] [Related]

  • 9. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of NSF following intravenous gadolinium-contrast media administration in dialysis patients with endstage renal disease.
    Heinz-Peer G, Neruda A, Watschinger B, Vychytil A, Geusau A, Haumer M, Weber M.
    Eur J Radiol; 2010 Oct 01; 76(1):129-34. PubMed ID: 19619969
    [Abstract] [Full Text] [Related]

  • 11. Toxicity of contrast media: an update.
    ten Dam MA, Wetzels JF.
    Neth J Med; 2008 Nov 01; 66(10):416-22. PubMed ID: 19011267
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk factors for NSF: a literature review.
    Prince MR, Zhang HL, Roditi GH, Leiner T, Kucharczyk W.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1298-308. PubMed ID: 19937930
    [Abstract] [Full Text] [Related]

  • 14. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
    Weinreb JC, Abu-Alfa AK.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1236-9. PubMed ID: 19938035
    [Abstract] [Full Text] [Related]

  • 15. Ten-year experience with nephrogenic systemic fibrosis: case-control analysis of risk factors.
    Bahrami S, Raman SS, Sauk S, Salehmoghaddam S, Villablanca JP, Finn JP, Lu DS.
    J Comput Assist Tomogr; 2009 Dec 01; 33(6):819-23. PubMed ID: 19940643
    [Abstract] [Full Text] [Related]

  • 16. MR imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety.
    Juluru K, Vogel-Claussen J, Macura KJ, Kamel IR, Steever A, Bluemke DA.
    Radiographics; 2009 Dec 01; 29(1):9-22. PubMed ID: 19019996
    [Abstract] [Full Text] [Related]

  • 17. Revisiting nephrogenic systemic fibrosis in 6 kidney transplant recipients: a single-center experience.
    Lemy AA, del Marmol V, Kolivras A, High WA, Matos C, Laporte M, Nortier JL.
    J Am Acad Dermatol; 2010 Sep 01; 63(3):389-99. PubMed ID: 20619488
    [Abstract] [Full Text] [Related]

  • 18. Nephrogenic system fibrosis: a radiologist's practical perspective.
    Martin DR.
    Eur J Radiol; 2008 May 01; 66(2):220-4. PubMed ID: 18321672
    [Abstract] [Full Text] [Related]

  • 19. Removal of gadolinium by dialysis: review of different strategies and techniques.
    Silberzweig JI, Chung M.
    J Magn Reson Imaging; 2009 Dec 01; 30(6):1347-9. PubMed ID: 19937933
    [Abstract] [Full Text] [Related]

  • 20. Nephrogenic systemic fibrosis--implications for nephrologists.
    Saab G, Abu-Alfa A.
    Eur J Radiol; 2008 May 01; 66(2):208-12. PubMed ID: 18342470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.